General Information of Drug (ID:
DR1640) |
Drug Name |
Trifarotene
|
Synonyms |
Trifarotene; Trifarotene (USAN/INN); Trifarotene [USAN:INN]; CD 5789; CD5789; SCHEMBL381493; compound 15b [PMID: 29706423]; 0J8RN2W0HK; 3''-Tert-butyl-4'-(2-hydroxyethoxy)-4''-(pyrrolidin-1-yl)(1,1':3',1'')terphenyl-4-carboxylic acid; 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid; 895542-09-3; CHEMBL3707313; CS-0018407; D11225; DB12808; DTXSID30237781; EX-A2704; GTPL9962; HY-100256; UNII-0J8RN2W0HK
|
Indication |
Acne vulgaris
[ICD11: ED80]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
459.6 |
Topological Polar Surface Area |
70 |
Heavy Atom Count |
34 |
Rotatable Bond Count |
8 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 11518241
- PubChem SID
-
16620175
; 23646324
; 79657850
; 141152560
; 163642844
; 198936619
; 226712396
; 247778990
- CAS Number
-
- TTD Drug ID
- D06FOU
- Formula
- C29H33NO4
- Canonical SMILES
- CC(C)(C)C1=C(C=CC(=C1)C2=C(C=CC(=C2)C3=CC=C(C=C3)C(=O)O)OCCO)N4CCCC4
- InChI
- 1S/C29H33NO4/c1-29(2,3)25-19-23(10-12-26(25)30-14-4-5-15-30)24-18-22(11-13-27(24)34-17-16-31)20-6-8-21(9-7-20)28(32)33/h6-13,18-19,31H,4-5,14-17H2,1-3H3,(H,32,33)
- InChIKey
- MFBCDACCJCDGBA-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.